NO20044090L - Substituted 3-Phenyl-5-alkoxy-1,3,4-oxadiazole-24 neR, its preparation and use in medicaments - Google Patents

Substituted 3-Phenyl-5-alkoxy-1,3,4-oxadiazole-24 neR, its preparation and use in medicaments

Info

Publication number
NO20044090L
NO20044090L NO20044090A NO20044090A NO20044090L NO 20044090 L NO20044090 L NO 20044090L NO 20044090 A NO20044090 A NO 20044090A NO 20044090 A NO20044090 A NO 20044090A NO 20044090 L NO20044090 L NO 20044090L
Authority
NO
Norway
Prior art keywords
ner
oxadiazole
medicaments
alkoxy
phenyl
Prior art date
Application number
NO20044090A
Other languages
Norwegian (no)
Inventor
Guenter Mueller
Hubert Heuer
Stefan Petry
Karl Schoenafinger
Armin Bauer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20044090L publication Critical patent/NO20044090L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
NO20044090A 2002-02-28 2004-09-27 Substituted 3-Phenyl-5-alkoxy-1,3,4-oxadiazole-24 neR, its preparation and use in medicaments NO20044090L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (en) 2002-02-28 2002-02-28 Substituted 3-phenyl-5-alkoxy-1,3,4-oxidiazol-2-ones, their preparation and use in drugs
PCT/EP2003/001484 WO2003072555A1 (en) 2002-02-28 2003-02-14 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments

Publications (1)

Publication Number Publication Date
NO20044090L true NO20044090L (en) 2004-11-04

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044090A NO20044090L (en) 2002-02-28 2004-09-27 Substituted 3-Phenyl-5-alkoxy-1,3,4-oxadiazole-24 neR, its preparation and use in medicaments

Country Status (22)

Country Link
EP (1) EP1480960B1 (en)
JP (1) JP4486363B2 (en)
KR (1) KR20040095240A (en)
CN (1) CN1639137A (en)
AR (1) AR038701A1 (en)
AT (1) ATE557012T1 (en)
AU (1) AU2003226977A1 (en)
BR (1) BR0307921A (en)
CA (1) CA2477031A1 (en)
CO (1) CO5611146A2 (en)
DE (1) DE10208987A1 (en)
HR (1) HRP20040782A2 (en)
HU (1) HUP0402671A3 (en)
IL (1) IL163683A0 (en)
MA (1) MA27172A1 (en)
MX (1) MXPA04007960A (en)
NO (1) NO20044090L (en)
PE (1) PE20030928A1 (en)
PL (1) PL370423A1 (en)
RU (1) RU2004128933A (en)
TW (1) TW200400951A (en)
WO (1) WO2003072555A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
BRPI0517434A (en) 2004-10-25 2008-10-07 Solvay Pharm Gmbh pharmaceutical compositions comprising cannabinoid cb1 receptor antagonists and potassium channel openers for the treatment of type i diabetes mellitus, obesity and related conditions
WO2009084970A1 (en) * 2007-12-27 2009-07-09 Bial-Portela & Companhia, S.A. 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
WO2010074587A2 (en) 2008-12-23 2010-07-01 Bial - Portela & Ca., S.A. 5-o-substituted 3-n-aryl-1,3,4-oxadiazolones for medical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (en) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, their manufacture and use in medicinal products
WO2001066531A1 (en) * 2000-03-07 2001-09-13 Aventis Pharma Deutschland Gmbh Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase

Also Published As

Publication number Publication date
JP4486363B2 (en) 2010-06-23
RU2004128933A (en) 2005-04-20
HUP0402671A2 (en) 2005-04-28
CA2477031A1 (en) 2003-09-04
IL163683A0 (en) 2005-12-18
AU2003226977A1 (en) 2003-09-09
PE20030928A1 (en) 2003-12-17
EP1480960A1 (en) 2004-12-01
EP1480960B1 (en) 2012-05-09
JP2005519085A (en) 2005-06-30
HRP20040782A2 (en) 2005-02-28
CO5611146A2 (en) 2006-02-28
DE10208987A1 (en) 2003-09-11
ATE557012T1 (en) 2012-05-15
MXPA04007960A (en) 2004-11-26
MA27172A1 (en) 2005-01-03
TW200400951A (en) 2004-01-16
PL370423A1 (en) 2005-05-30
AR038701A1 (en) 2005-01-26
KR20040095240A (en) 2004-11-12
BR0307921A (en) 2004-12-21
HUP0402671A3 (en) 2006-07-28
CN1639137A (en) 2005-07-13
WO2003072555A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
NO20052855D0 (en) Phosphonoxycinazoline derivatives and their pharmaceutical use.
IS8074A (en) Substituted 1,4- Diazepines and their use
DK1354888T3 (en) Glucopyranosyloxypyrazole derivatives and their use in drugs
HK1076110A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
NO20051983D0 (en) 3-phenyl-substituted pyridoindolone, its preparation and therapeutic use thereof.
NO20053593D0 (en) Arylalkylcarbamate derivatives, method and use thereof in therapy
IS6661A (en) Benzimidazole derivatives, their preparation and therapeutic use
EE200300311A (en) Phthalazinone-piperidine derivatives, their use and medicine
HK1081954A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
ITRM20020042U1 (en) MODULAR HANDLE PERFECTED, IN PARTICULAR HANDLE FOR PURPOSES AND SIMILAR.
DK1417189T3 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
PT1525193E (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
IS2487B (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
ZA200210316B (en) Composition and its therapeutic use.
IS7961A (en) Diarylmethylidene piperidine derivatives, their formulations and their use
NO20044090L (en) Substituted 3-Phenyl-5-alkoxy-1,3,4-oxadiazole-24 neR, its preparation and use in medicaments
IS7259A (en) 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino [4,5-b] indole-1-carboxamide derivatives, their preparation and their use in the treatment
NO20045723D0 (en) Nitrogen-containing compound, preparation thereof and use in amino-aldehyde resins
AU2003217023A8 (en) Cyclopentenone derivatives, their preparation and use in medecime
SI1513835T1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
SI1513836T1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
SI1525198T1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
SI1525193T1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
SI1492792T1 (en) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino(4,5-b) indole-1-acetamide derivatives, preparation and use thereof in medicaments
SE0202516D0 (en) Novel compounds, their use, and preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application